$83.33
0%
Price vs. AI Score (Last 150 days)
Data gathered: December 4
Data gathered: December 4
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 31 3.3% |
|
| Sentiment | 57 0% |
|
| Webpage traffic | 22,000 -4.4% |
|
| Employee Rating | 91 0% |
|
| Google Adspend | $18 -55% |
|
| Google Trends | 7 -65% |
|
| Linkedin Employees | 1,328 N/A |
|
| Patents | 119 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 334 0.9% |
|
| Facebook followers | 8,971 0% |
|
| Stocktwits Mentions | 5 0% |
|
| Stocktwits Subscribers | 18,580 0% |
|
| Twitter Followers | 5,264 0% |
|
| Instagram Followers | 4,279 -0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 93 0% |
|
In the news
 |
Sarepta Therapeutics (SRPT) Up 4.5% Since Last Earnings Report: Can It Continue?December 1 - Yahoo |
 |
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 30 - Yahoo |
 |
Wall Street Analysts Think Sarepta Therapeutics (SRPT) Could Surge 82.64%: Read This Before Placing a BetNovember 28 - Yahoo |
 |
When Will Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Turn A Profit?November 28 - Yahoo |
 |
11 Best Upside Stocks To Buy Right NowNovember 26 - Yahoo |
 |
13 Stocks Insiders are Buying NowNovember 23 - Yahoo |
About Sarepta Therapeutics
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
| Price | $83.33 |
| Target Price | Sign up |
| Market Cap | $7.9B |
| Dividend Yield | 0.0126 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 332M | 149M | 183M | -41M | -28M |
| Q2 '23 | 261M | 119M | 142M | -24M | -9.2M |
| Q1 '23 | 254M | 111M | 143M | -517M | -506M |
| Q4 '22 | 258M | 123M | 135M | -109M | -94M |
| Q3 '22 | 230M | 105M | 125M | -258M | -242M |
Insider Transactions
| INGRAM DOUGLAS S filed to buy 390,307 shares at $81.3. November 6 '23 |
| Barry Richard filed to buy 140,000 shares at $78.8. November 6 '23 |
| Chambers Michael Andrew filed to buy 246,996 shares at $109.9. August 15 '23 |
| Chambers Michael Andrew filed to buy 237,017 shares at $108.1. August 14 '23 |
| Chambers Michael Andrew filed to buy 213,331 shares at $106.3. August 11 '23 |
Read more about Sarepta Therapeutics and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, instagram followers, news mentions, reddit mentions, business outlook.